{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:30:29Z","timestamp":1792704629566,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>IMPORTANCE:<\/jats:title>\n            <jats:p>Vasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To determine the association between norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN, SETTING, AND PARTICIPANTS:<\/jats:title>\n            <jats:p>Retrospective, observational evaluation utilizing Medical Information Mart for Intensive Care-IV and electronic ICU Collaborative Research Database databases of adult patients with septic shock based on modified Sepsis-3 criteria receiving continuous infusion catecholamines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOMES AND MEASURES:<\/jats:title>\n            <jats:p>The associations of norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality were evaluated with multivariable regression models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>In total, 1409 patients from 209 hospitals were included. At vasopressin initiation patients had a median (interquartile range) norepinephrine-equivalent dose 28.4 \u00b5g\/min (16.4\u201342.6 \u00b5g\/min), lactate concentration 3.7 mmol\/L (2.5\u20136.2 mmol\/L), and 5.6 hours (2.0\u201313.5\u2009hr) had elapsed since shock onset. All three variables of interest were associated with in-hospital mortality. Three restricted cubic spline knots were identified where the relationship between norepinephrine-equivalent dose and in-hospital mortality changed substantially: 9, 28, and 72 \u00b5g\/min. The odds of in-hospital mortality increased by 90% and 3.9-fold when comparing vasopressin initiation at norepinephrine-equivalent doses of 28 \u00b5g\/min and 72 \u00b5g\/min to 9 \u00b5g\/min, respectively (adjusted odds ratio [OR], 1.90 [95% CI, 1.49\u20132.41] and 3.93 [95% CI, 2.74\u20135.64]). The odds of in-hospital mortality increased by 16% for every mmol\/L in the lactate concentration at vasopressin initiation (adjusted OR, 1.16 [95% CI, 1.11\u20131.21]). Finally, the odds of in-hospital mortality increased by 3% for every hour in the time duration from shock onset to vasopressin initiation (adjusted OR, 1.03 [95% CI, 1.01\u20131.04]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS AND RELEVANCE:<\/jats:title>\n            <jats:p>Earlier adjunctive vasopressin initiation may decrease mortality in patients with septic shock.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001284","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T16:00:10Z","timestamp":1755878410000},"page":"e1284","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases"],"prefix":"10.1097","volume":"7","author":[{"given":"Gretchen L.","family":"Sacha","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Duggal","sequence":"additional","affiliation":[{"name":"Critical Care Center, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita J.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Critical Care Center, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth R.","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"R1-20250822","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.chest.2016.07.010","article-title":"Estimating ten-year trends in septic shock incidence and mortality in United States Academic Medical Centers using clinical data.","volume":"151","author":"Kadri","year":"2017","journal-title":"Chest"},{"key":"R2-20250822","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: A systematic review and meta-analysis.","volume":"23","author":"Vincent","year":"2019","journal-title":"Crit Care"},{"key":"R3-20250822","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CCM.0000000000004224","article-title":"Sepsis among Medicare beneficiaries: 1. The burdens of sepsis, 2012-2018.","volume":"48","author":"Buchman","year":"2020","journal-title":"Crit Care Med"},{"key":"R4-20250822","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R5-20250822","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial.","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"R6-20250822","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12630-019-01546-x","article-title":"Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock.","volume":"67","author":"Honarmand","year":"2020","journal-title":"Can J Anaesth"},{"key":"R7-20250822","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","article-title":"The effects and safety of vasopressin receptor agonists in patients with septic shock: A meta-analysis and trial sequential analysis.","volume":"23","author":"Jiang","year":"2019","journal-title":"Crit Care"},{"key":"R8-20250822","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: An individual patient data meta-analysis of randomised controlled trials.","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"key":"R9-20250822","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00134-011-2407-x","article-title":"Vasopressin for treatment of vasodilatory shock: An ESICM systematic review and meta-analysis.","volume":"38","author":"Polito","year":"2012","journal-title":"Intensive Care Med"},{"key":"R10-20250822","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R11-20250822","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and meta-analysis.","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"R12-20250822","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials.","volume":"16","author":"Serpa Neto","year":"2012","journal-title":"Crit Care"},{"key":"R13-20250822","first-page":"1760","article-title":"Epidemiology of vasopressin use for adults with septic shock.","volume":"13","author":"Vail","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R14-20250822","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2017.2841","article-title":"Association between US norepinephrine shortage and mortality among patients with septic shock.","volume":"317","author":"Vail","year":"2017","journal-title":"JAMA"},{"key":"R15-20250822","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/CCM.0000000000005305","article-title":"Association between vasopressin rebranding and utilization in patients with septic shock.","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"R16-20250822","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.chest.2023.07.009","article-title":"Optimizing vasopressin use and initiation timing in septic shock: A narrative review.","volume":"164","author":"Sacha","year":"2023","journal-title":"Chest"},{"key":"R17-20250822","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock.","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"R18-20250822","article-title":"MIMIC-IV (Version 2.2). PhysioNet.","author":"Johnson","year":"2023"},{"key":"R19-20250822","doi-asserted-by":"crossref","first-page":"E215","DOI":"10.1161\/01.CIR.101.23.e215","article-title":"PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals.","volume":"101","author":"Goldberger","year":"2000","journal-title":"Circulation"},{"key":"R20-20250822","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R21-20250822","article-title":"eICU Collaborative Research Database (Version 2.0). PhysioNet.","author":"Pollard","year":"2019"},{"key":"R22-20250822","doi-asserted-by":"crossref","first-page":"180178","DOI":"10.1038\/sdata.2018.178","article-title":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research.","volume":"5","author":"Pollard","year":"2018","journal-title":"Sci Data"},{"key":"R23-20250822","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R24-20250822","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1513\/AnnalsATS.202102-196OC","article-title":"Practice patterns in the initiation of secondary vasopressors and adjunctive corticosteroids during septic shock in the United States.","volume":"18","author":"Bosch","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"R25-20250822","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"R26-20250822","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/MLR.0b013e318268ac86","article-title":"Identifying patients with severe sepsis using administrative claims: Patient-level validation of the Angus implementation of the international consensus conference definition of severe sepsis.","volume":"52","author":"Iwashyna","year":"2014","journal-title":"Med Care"},{"key":"R27-20250822","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"R28-20250822","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciy724","article-title":"Incidence of acute kidney injury among critically ill patients with brief empiric use of antipseudomonal beta-lactams with vancomycin.","volume":"68","author":"Schreier","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R29-20250822","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R30-20250822","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock.","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R31-20250822","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/aje\/148.7.631","article-title":"Use of two-segmented logistic regression to estimate change-points in epidemiologic studies.","volume":"148","author":"Pastor","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R33-20250822","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: Presenting and interpreting confounder and modifier coefficients.","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R34-20250822","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1513\/AnnalsATS.201808-564PS","article-title":"Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals.","volume":"16","author":"Lederer","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R35-20250822","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12879-023-08147-6","article-title":"Timing of vasopressin initiation and mortality in patients with septic shock: Analysis of the MIMIC-III and MIMIC-IV databases.","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R36-20250822","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1001\/jama.2025.3046","article-title":"Optimal vasopressin initiation in septic shock: The OVISS Reinforcement Learning Study.","volume":"333","author":"Kalimouttou","year":"2025","journal-title":"JAMA"},{"key":"R37-20250822","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.chest.2023.04.023","article-title":"In patients with sepsis, initial lactate clearance is confounded highly by comorbidities and poorly predicts subsequent lactate trajectory.","volume":"164","author":"McCallister","year":"2023","journal-title":"Chest"},{"key":"R38-20250822","first-page":"298","article-title":"Blood lactate levels in sepsis: In 8 questions.","volume":"27","author":"Vincent","year":"2021","journal-title":"Curr Opin Crit Care"},{"key":"R39-20250822","article-title":"Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis (NoVa). ClinicalTrials.gov."},{"key":"R40-20250822","article-title":"Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock (EVSS). ClinicalTrials.gov."},{"key":"R41-20250822","article-title":"Vasopressin for Septic Shock Pragmatic Trial (VASSPR). ClinicalTrials.gov."},{"key":"R42-20250822","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force.","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit Care Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T16:00:16Z","timestamp":1755878416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001284","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}